Index of reports
> Cases with Pneumonia (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Etodolac where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Etodolac side effects in 51 year old male
Reported by a consumer/non-health professional from United States on 2012-07-18
Patient: 51 year old male, weighing 87.5 kg (192.6 pounds)
Reactions: Night Sweats, Muscle Atrophy, Swelling Face, Body FAT Disorder, CD4 Lymphocytes Decreased, Pneumonia, Abnormal Behaviour, Rash, Amnesia, Malaise, Mood Altered, Oedema Peripheral, Hiccups, Bronchitis, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Etodolac
Possible Etodolac side effects in female
Reported by a physician from Japan on 2012-07-11
Patient: female, weighing 42.0 kg (92.4 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: started before 20-jan-2006
Administration route: Oral
Indication: Rheumatoid Arthritis
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
Remicade
Start date: 2008-09-08
Etodolac
Administration route: Oral
Indication: Rheumatoid Arthritis
Remicade
Indication: Rheumatoid Arthritis
Start date: 2008-08-25
Remicade
Dosage: 20th infusion
Start date: 2012-01-06
Remicade
Start date: 2012-04-12
Possible Etodolac side effects in 54 year old male
Reported by a physician from United States on 2012-05-29
Patient: 54 year old male, weighing 84.4 kg (185.6 pounds)
Reactions: Night Sweats, Pneumonia, Nausea, Abnormal Behaviour, Disorientation, Rash, Amnesia, Mood Altered, Oedema Peripheral, Hiccups, Disturbance in Attention, Bronchitis, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Etodolac
Possible Etodolac side effects in female
Reported by a physician from Japan on 2012-03-21
Patient: female
Reactions: White Blood Cell Count Decreased, Pneumonia, Stomatitis, Duodenal Ulcer, Pyrexia, Constipation, Gastric Ulcer, Hypokalaemia, Haemoglobin Decreased, Decubitus Ulcer, Interstitial Lung Disease, Platelet Count Decreased, Leukopenia, Pharyngitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-15
End date: 2011-07-02
Prednisolone
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-05-18
End date: 2011-07-02
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2010-08-27
End date: 2010-09-06
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-01-13
End date: 2011-02-03
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-03-09
End date: 2011-03-22
Cyclophosphamide
Dosage: 50 milligram
Administration route: Oral
Start date: 2011-04-15
End date: 2011-04-16
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2010-09-08
End date: 2010-09-14
Dexamethasone Acetate
Dosage: 4 milligram
Administration route: Oral
Start date: 2011-02-09
End date: 2011-03-08
Cyclophosphamide
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-30
End date: 2011-04-14
Etodolac
Dosage: 400 milligram
Administration route: Oral
Start date: 2010-10-01
End date: 2010-12-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-29
End date: 2010-08-19
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-05-18
End date: 2011-06-07
Dexamethasone Acetate
Dosage: 16 milligram
Administration route: Oral
Start date: 2011-03-09
End date: 2011-03-22
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-10-04
End date: 2010-10-25
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-11-01
End date: 2010-11-21
Prednisolone
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-30
End date: 2011-04-19
Prednisolone
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-07-20
End date: 2011-07-29
Etodolac
Dosage: 400 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-29
End date: 2010-09-24
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-02-09
End date: 2011-03-01
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-03-30
End date: 2011-04-19
Dexamethasone Acetate
Dosage: 4 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-13
End date: 2011-02-09
Cyclophosphamide
Dosage: 50 milligram
Administration route: Oral
Start date: 2011-06-15
End date: 2011-07-02
Other drugs received by patient: Dexamethasone Sodium Phosphate; Omeprazole; Bisolvon; Kary UNI; Oxinorm; Decadron; Dexamethasone Sodium Phosphate; Amitriptyline HCL; Oxycontin; Kaytwo N; Dexamethasone Sodium Phosphate; Oxycontin; Oxycontin; Decadron; Omeprazole; Oxycontin; Solu-Cortef; Gran; Decadron; Magnesium Sulfate; Magnesium Sulfate; Magnesium Sulfate; Aspirin; Oxycontin; Oxycontin; Alloid G; Oxinorm; Dexamethasone Sodium Phosphate; Dexamethasone Sodium Phosphate; Omeprazole; Amitriptyline HCL; Oxycontin; Kary UNI; Kary UNI; Dexamethasone Sodium Phosphate; Amitriptyline HCL; Aspirin; Valganciclovir; Petrolatum; Decadron; Dexamethasone Sodium Phosphate; Dexamethasone Sodium Phosphate; Oxycontin; Oxycontin; Zometa; Oxinorm; Oxinorm
Possible Etodolac side effects in female
Reported by a physician from Japan on 2012-02-28
Patient: female
Reactions: White Blood Cell Count Decreased, Pneumonia, Stomatitis, Duodenal Ulcer, Pyrexia, Gastric Ulcer, Constipation, Hypokalaemia, Haemoglobin Decreased, Decubitus Ulcer, Interstitial Lung Disease, Platelet Count Decreased, Pharyngitis, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone Acetate
Dosage: 4 milligram
Administration route: Oral
Start date: 2011-02-09
End date: 2011-03-08
Prednisolone
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-30
End date: 2011-04-19
Dexamethasone Acetate
Dosage: 4 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-13
End date: 2011-02-10
Cyclophosphamide
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-30
End date: 2011-04-14
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-29
End date: 2010-08-19
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2010-09-08
End date: 2010-09-14
Cyclophosphamide
Dosage: 50 milligram
Administration route: Oral
Start date: 2011-04-15
End date: 2011-04-16
Prednisolone
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-05-18
End date: 2011-07-02
Prednisolone
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-07-20
End date: 2011-07-29
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-01-13
End date: 2011-02-03
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-03-30
End date: 2011-04-19
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-05-18
End date: 2011-06-07
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2010-08-27
End date: 2010-09-06
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-11-01
End date: 2010-11-21
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-02-09
End date: 2011-03-01
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-10-04
End date: 2010-10-25
Etodolac
Dosage: 400 milligram
Administration route: Oral
Start date: 2010-10-01
End date: 2010-12-01
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-03-09
End date: 2011-03-22
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-15
End date: 2011-07-02
Dexamethasone Acetate
Dosage: 16 milligram
Administration route: Oral
Start date: 2011-03-09
End date: 2011-03-22
Cyclophosphamide
Dosage: 50 milligram
Administration route: Oral
Start date: 2011-06-15
End date: 2011-07-02
Etodolac
Dosage: 400 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-29
End date: 2010-09-24
Other drugs received by patient: Omeprazole; Aspirin; Zometa; Kary UNI; Valganciclovir; Gran; Dexamethasone Sodium Phosphate; Dexamethasone Sodium Phosphate; Omeprazole; Magnesium Sulfate; Oxycontin; Oxycontin; Oxinorm; Petrolatum; Solu-Cortef; Magnesium Sulfate; Amitriptyline HCL; Oxycontin; Oxycontin; Kaytwo N; Dexamethasone Sodium Phosphate; Aspirin; Oxycontin; Oxinorm; Dexamethasone Sodium Phosphate; Oxycontin; Kary UNI; Oxinorm; Oxinorm; Dexamethasone Sodium Phosphate; Magnesium Sulfate; Dexamethasone Sodium Phosphate; Dexamethasone Sodium Phosphate; Omeprazole; Amitriptyline HCL; Amitriptyline HCL; Bisolvon; Oxycontin; Kary UNI; Decadron; Decadron; Decadron; Decadron; Dexamethasone Sodium Phosphate; Oxycontin; Oxycontin; Alloid G
Possible Etodolac side effects in 65 year old male
Reported by a pharmacist from United States on 2012-01-31
Patient: 65 year old male, weighing 83.3 kg (183.3 pounds)
Reactions: Haemoglobin Decreased, Pneumonia, Fatigue, Haemorrhage, Melaena, Occult Blood Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Etodolac
Possible Etodolac side effects in male
Reported by a physician from Japan on 2011-12-14
Patient: male, weighing 52.0 kg (114.4 pounds)
Reactions: Pneumonia Aspiration, Pneumonia, Overdose, Duodenal Ulcer Haemorrhage, Altered State of Consciousness
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Etodolac
Administration route: Oral
Indication: Cancer Pain
Start date: 2011-10-13
End date: 2011-10-17
Avastin
Indication: Colon Cancer Recurrent
Start date: 2011-05-11
End date: 2011-01-01
Avastin
Start date: 2011-06-29
End date: 2011-10-07
Other drugs received by patient: Fentanyl Citrate; Fluorouracil; Oxaliplatin; Fentanyl Citrate; Fluorouracil; Lyrica; Levoleucovorin Calcium; Lyrica
Possible Etodolac side effects in male
Reported by a physician from Japan on 2011-11-30
Patient: male, weighing 52.0 kg (114.4 pounds)
Reactions: Pneumonia, Pneumonia Aspiration, Duodenal Ulcer Haemorrhage
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Etodolac
Administration route: Oral
Indication: Cancer Pain
Start date: 2011-10-13
End date: 2011-10-17
Avastin
Indication: Colon Cancer Recurrent
Start date: 2011-05-11
End date: 2011-10-07
Other drugs received by patient: Fluorouracil; Oxaliplatin; Fentanyl Citrate; Fentanyl Citrate; Fluorouracil; Lyrica; Levoleucovorin Calcium; Lyrica
|